5Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire[ J]. Respir Med,1991,85( Suppl B) :25-31 ;discussion 55-37.
6Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of teahh status for chronic airflow limitation. The St. George' s Respiratory Quesionnaire[ J]. Am Rev Respir Dis,1992,145(6) :1321-1327.
7Sin DD, Man SF. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease [ J ]. Proc Am Thorae Soc,2006,3 (7) :624-629.
8Halpin D. Mortality in COPD:inevitable or preventable? Insights from the zardiovascular arena[ J ]. COPD ,2008,5 (3) :187-200.
9Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease [ J ]. Thorax,2005,60 ( 11 ) :925-951.
10Carr SJ, Hill K, Brooks D,et al. Pulmonary Rehabilitation After Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients Who Previously Completed a Pulmonary Rehabilitation Program [ J ]. J Cardiopulm Rehabil Prey,2009,29 (5) :318-324.
